It blocks the action of a vital enzyme (protease) and stops SARS-CoV-2 from making copies of itself.The trial included 1,219 “high risk” adults with COVID who were not in hospital. Each person had at least one characteristic or underlying medical condition associated with an increased risk of developing severe COVID. This may include whether it would be available from GPs, and what sort of patient risk factors would be considered.Paxlovid is one potential COVID drug for use at home. It's been approved for use in the UK, and is being considered for use in Australia.Then there's's emerging COVID drug Evusheld . Some medicines subsidised by the government for other conditions can cost almost Australian dollars 19,000 per pack of tablets.

Source: Economic Times November 13, 2021 18:26 UTC